RSV entry inhibitors block F-protein mediated fusion with model membranes
- 18 April 2002
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 55 (1) , 189-200
- https://doi.org/10.1016/s0166-3542(02)00050-5
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Sensitivity of Human Immunodeficiency Virus Type 1 to the Fusion Inhibitor T-20 Is Modulated by Coreceptor Specificity Defined by the V3 Loop of gp120Journal of Virology, 2000
- The Fusion Glycoprotein of Human Respiratory Syncytial Virus Facilitates Virus Attachment and Infectivity via an Interaction with Cellular Heparan SulfateJournal of Virology, 2000
- Respiratory Syncytial Virus Infection in AdultsClinical Microbiology Reviews, 2000
- Inhibition of respiratory syncytial virus by a new class of chemotherapeutic agentsDrugs of the Future, 2000
- Novel and Specific Respiratory Syncytial Virus Inhibitors That Target Virus FusionJournal of Medicinal Chemistry, 1998
- Capture of an early fusion-active conformation of HIV-1 gp41Nature Structural & Molecular Biology, 1998
- Respiratory Syncytial Virus Is an Important Cause of Community-Acquired Lower Respiratory Infection among Hospitalized AdultsThe Journal of Infectious Diseases, 1996
- Live Subgroup B Respiratory Syncytial Virus Vaccines that Are Attenuated, Genetically Stable, and Immunogenic in Rodents and Nonhuman PrimatesThe Journal of Infectious Diseases, 1996
- Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes.Proceedings of the National Academy of Sciences, 1993
- Ribavirin therapy of adult respiratory syncytial virus pneumonitisArchives of internal medicine (1960), 1991